Radiation-Induced Myelosuppression Treatment Market to Incur Rapid Extension During 2018 to 2028: Novartis AG, Pfizer Inc., Janssen Global Services, Partner Therapeutics
Rapidly improving healthcare infrastructure and reimbursement scenario has been a major booster for the healthcare industry in developing regional markets. With incessantly increasing number of cancer cases, it is more likely that the subsequent demand for a wide range of treatments adopted to treat cancer patients would also remain on a constant rise over the course of coming years.
View full press release